2
Press Release: STADA’s Strong Growth Journey Continues in 2025
Ein Dokument
mehr
Storys zum Thema Krankheit
Press Release: STADA invests more than €85m in Saudi Arabia manufacturing hub
Ein DokumentmehrPress Release: STADA and Bio-Thera receive European Marketing Authorization for Gotenfia, a Biosimilar to Simponi
STADA and Bio-Thera receive European Marketing Authorization for Gotenfia, a Biosimilar to Simponi - European Commission grants approval for Gotenfia®, a golimumab biosimilar to Simponi® that was developed by Bio-Thera and will be marketed by STADA ...
Ein DokumentmehrPress Release: Golimumab biosimilar Gotenfia from STADA and Bio-Thera receives positive CHMP opinion
Golimumab biosimilar Gotenfia from STADA and Bio-Thera receives positive CHMP opinion - Positive opinion from European Medicines Agency supports approval for golimumab biosimilar Gotenfia® developed by Bio-Thera and to be marketed by STADA - ...
Ein DokumentmehrPress Release: STADA obtains approvals to bring denosumab biosimilars in bone-health and oncology to patients in Europe
STADA obtains approvals to bring denosumab biosimilars in bone-health and oncology to patients in Europe - European Commission approves STADA’s Kefdensis® and Zvogra® denosumab biosimilars for all indications of reference medicines Prolia® and ...
3 DokumentemehrPress release: Bio-Thera and STADA Extend Biosimilars Alliance to Tocilizumab
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURES. Press release ...
Ein Dokumentmehr
Less than 30 days left to apply – don’t miss your chance
Ein DokumentmehrcanSERV Open Call relaunches: Apply now for Free Access to Cutting-Edge Cancer Research Services
Ein Dokumentmehr- 3
Press Release STADA’s growth journey continues in 2024 - Significant increase in sales and profits - Growing ahead of the market
Ein Dokumentmehr GEA launches Body Condition Scoring for cows
Ein DokumentmehrLast Call for canSERV Third Open Call Funding
Ein DokumentmehrEvent Announcement: VIROFIGHT Hybrid Symposium
Ein Dokumentmehr
Launch of canSERV Call for Service Provision – "Training the Next Generation of Cancer Researchers"
Ein Dokumentmehr- 2
Fundació Puigvert validates a new tool capable of selecting the most suitable antibiotic for uncomplicated urinary tract infections within 45 minutes.
Ein Dokumentmehr - 2
Record financing rounds at the Munich biotech hub
Ein Dokumentmehr canSERV relaunches Open Call for Service Provision
Ein DokumentmehrPress release: STADA continues strong growth journey in the first half of 2024
Ein DokumentmehrcanSERV to Accelerate Your Cancer Research - 2 Calls for Service Provision Open
2 Dokumentemehr
- 4
Sysmex’s PA-100 AST System Wins One of the UK’s Biggest Science Prizes
Ein Dokumentmehr Press release: Alvotech and STADA add to strategic alliance through denosumab partnership
Alvotech and STADA add to strategic alliance through denosumab partnership - STADA assumes marketing license for Alvotech’s proposed biosimilar referencing Prolia®/Xgeva® (denosumab) in Europe, including Switzerland and the UK, as well as rights in selected markets in Central Asia and the Middle ...
Ein DokumentmehrLeipzig Tourismus und Marketing GmbH
5Pioneering Heart Surgery and Medical Congresses in Leipzig
Ein Dokumentmehr- 2
Press release : People with Parkinson’s experience variations in effects of oral medicines, but lack advice, international survey reveals
Ein Dokumentmehr - 5
Press Release - hubergroup India expands its support for rural healthcare
Ein Dokumentmehr Innovation and Start-up Center Biotechnology (IZB) welcomes Invitris
Ein Dokumentmehr
Innovation and Start-Up Center for Biotechnology (IZB) welcomes new start-up Origin.Bio
Ein Dokumentmehr- 2
The start-up Eisbach Bio in the IZB near Munich receives 6.7 million euros from the Bavarian state government for the development of a COVID-19 therapeutics
Ein Dokumentmehr - 2
COVID-19: Start-up Eisbach Bio at the IZB receives EUR 8 million government grant
Ein Dokumentmehr - 7
Biotech start-ups at the IZB close deals worth more than 140 million EUR in the first half of 2021
Ein Dokumentmehr - 2
Lindis Biotech develops immunotherapy against bladder cancer
Ein Dokumentmehr Origenis founds biotech company Neuron23 in Silicon Valley together with star investor Kleiner Perkins
Ein Dokumentmehr
12Nächste